Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
Condition(s):Septic Shock; Shock; Sepsis; Systemic Inflammatory Response SyndromeLast Updated:November 8, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Septic Shock; Shock; Sepsis; Systemic Inflammatory Response SyndromeLast Updated:November 8, 2023Not yet recruiting
Condition(s):Liver Transplant; Complications; VasoplegiaLast Updated:December 21, 2023Recruiting
Condition(s):Septic Shock; Vasodilatory ShockLast Updated:October 6, 2023Recruiting
Condition(s):PreeclampsiaLast Updated:December 6, 2023Recruiting
Condition(s):Distributive ShockLast Updated:November 13, 2023Recruiting
Condition(s):HypertensionLast Updated:May 6, 2023Recruiting
Condition(s):Preeclampsia PostpartumLast Updated:July 10, 2023Recruiting
Condition(s):Exercise PhysiologyLast Updated:November 30, 2023Recruiting
Condition(s):PreeclampsiaLast Updated:May 17, 2022Recruiting
Condition(s):Septic Shock; Acute Kidney InjuryLast Updated:January 31, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.